Shares of Bone Biologics Corp. (BBLG) are currently gaining nearly 80% on Monday morning. Jeffrey Frelick, the company's president and chief executive officer, is set to present at the H.C. Wainwright BioConnect Virtual Conference being held January 10 - 13, 2022.
BBLG is currently trading at $6.11, up $2.68 or 78.13%, on the Nasdaq, on a heavy volume of 31 million shares, above average volume of 565 thousand shares.
Bone Biologics is a medical device company that focuses on bone regeneration in spinal fusion using the recombinant human protein. Its NELL-1/DBX is a combination product, which is an osteostimulative recombinant protein that provides target specific control over bone regeneration.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.